$BioCryst Pharmaceuticals (BCRX.US)$BioCryst Pharmaceuticals Inc: FDA Grants Priority Review of Application, With Pdufa Target Action Date of September 12, 2025
$BioCryst Pharmaceuticals (BCRX.US)$BioCryst Reports First Quarter 2025 Financial Results and Provides Business Update --Q1 2025 ORLADEYO net revenue of $134.2 million (+51 percent y-o-y)-- --Full year 2025 ORLADEYO revenue guidance increased to $580 million to $600 million-- --Company now expects to be profitable for full year 2025, a year ahead of schedule-- --Company pays down $75 million of debt; saves approximately $23.5 million over life of loan--
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.
BioCryst Pharmaceuticals Stock Forum
FDA-Approved ORLADEYO Expands to Colombia, Marking 6th Latin American Market for HAE Treatment
ORLADEYO Makes History: First Oral HAE Drug Now Reimbursed Across All Major European Markets
FDA Fast-Tracks First-Ever Oral HAE Treatment for Children Under 12: September Decision Expected
$BioCryst Pharmaceuticals (BCRX.US)$
--Q1 2025 ORLADEYO net revenue of $134.2 million (+51 percent y-o-y)--
--Full year 2025 ORLADEYO revenue guidance increased to $580 million to $600 million--
--Company now expects to be profitable for full year 2025, a year ahead of schedule--
--Company pays down $75 million of debt; saves approximately $23.5 million over life of loan--
dip = buy!
No comment yet